Natalie Evans, MD
- Clinical Assistant Professor
Natalie Evans, MD, is a vascular medicine physician and medical director for regional vascular laboratories of University Hospitals Harrington Heart & Vascular Institute. Dr. Evans earned her doctor of medicine degree from Drexel University College of Medicine in Philadelphia and completed her internal medicine residency and vascular medicine fellowship training at Northwestern University in Chicago. She previously worked at Cleveland Clinic for eight years, where she had leadership roles in the noninvasive vascular laboratory, pharmacy anticoagulation clinic, and quality and patient safety.
Dr. Evans treats a wide range of peripheral vascular diseases and is especially interested in the medical management of lower extremity peripheral artery disease, treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and diagnosis of hypercoagulable states. Dr. Evans is active with the Peripheral Vascular Disease Council of the American Heart Association and the Society for Vascular Medicine. She is the co-editor of the journal Vascular Medicine's vascular disease patient information page, which provides free downloadable handouts on numerous vascular disease topics.
- Carotid Artery Stenosis
- Chronic Venous Disease
- Deep Vein Thrombosis
- Hypercoagulable State
- Peripheral Artery Disease
- Peripheral Vascular Diseases
- Post-thrombotic Syndrome
- Pulmonary Embolism
- Raynaud’s Syndrome
- Thoracic Outlet Syndrome
- Vascular Medicine
- Vascular Ultrasound
- Venous Thromboembolism
Patient Satisfaction Reviews
0 out of 5
- Internal Medicine - American Board of Internal Medicine
Fellowship | Vascular Medicine
Vascular Medicine - Northwestern University Feinberg School Of Medicine (2008 - 2011)
Residency | Internal Medicine
Internal Medicine - Mcgaw Medical Center Of Northwestern University (2005 - 2008)
Northwestern University (2010)
Drexel University College Of Medicine (2005)
Western Kentucky University (1993)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Natalie Evans did not disclose any Outside Relationships with Industry.